Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

815
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
815
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

960
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
960
Depression: Overview01:18

Depression: Overview

1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression01:05

Long-term Depression

33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contextualizing racial differences in baseline neuropsychological assessment of collegiate athletes.

Journal of the International Neuropsychological Society : JINS·2026
Same author

Symptom clusters and cognitive changes: predictors of recovery timelines following concussion in college athletes.

Journal of clinical and experimental neuropsychology·2026
Same author

Quality of Life, Self-Reported Cognitive Difficulties, and Performance-Based Cognitive Problems in Multiple Sclerosis: What's Sleep Got to Do With It?

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same author

Get Your Brain in the Game: Using Machine Learning to Predict Recovery Timelines Following Sports-Related Concussion.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2025
Same author

Depressive Symptoms, Sleep Complaints, and Cognitive Performance: Examining the Mediating Role of Sleep in College Athletes.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2025
Same author

Coping is a moderator of relationships between cognitive fatigue and cognitive variability in multiple sclerosis.

Journal of the International Neuropsychological Society : JINS·2025

Related Experiment Video

Updated: Mar 9, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.3K

Beyond binary: Exploring the merits of three depression groups in multiple sclerosis.

Margaret H Cadden1, Jessica E Meyer1, Peter A Arnett1

  • 1Department of Psychology, The Pennsylvania State University.

Neuropsychology
|January 6, 2017
PubMed
Summary

Depression in multiple sclerosis (MS) is complex. Analyzing currently depressed, remitted depression, and never depressed groups reveals distinct patterns, offering deeper insights than a simple binary approach.

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K

Related Experiment Videos

Last Updated: Mar 9, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.3K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K

Area of Science:

  • Neurology
  • Psychiatry
  • Clinical Psychology

Background:

  • Depression is highly prevalent in multiple sclerosis (MS), affecting up to 50% of individuals.
  • Traditionally, depression in MS is viewed as a binary condition (depressed vs. not depressed).
  • This binary approach may oversimplify the complex nature of depression experienced by MS patients.

Purpose of the Study:

  • To investigate demographic, cognitive, illness-related, and psychosocial factors associated with depression in MS.
  • To compare three distinct groups: currently depressed, remitted depression, and never depressed individuals with MS.
  • To determine if a nuanced, multi-group analysis offers greater insight than a binary classification.

Main Methods:

  • Fifty-four individuals diagnosed with multiple sclerosis participated in the study.
  • Current depression was assessed using the Beck Depression Inventory-Fast Screen (BDI-FS).
  • Past depression and psychosocial factors were evaluated using the Structured Clinical Interview for DSM-IV Disorders (SCID-IV) and a semistructured interview.

Main Results:

  • Analyzing depression in three groups (currently depressed, remitted, never depressed) proved valuable for identifying risk, protective, and compensatory factors in MS.
  • No single, consistent pattern of functioning was observed across all variables for the remitted depression group compared to the never depressed group.
  • Significant differences emerged between the remitted and never depressed groups, highlighting the limitations of a combined 'not currently depressed' category.

Conclusions:

  • Viewing depression in multiple sclerosis as a binary construct can obscure critical information about its complex relationships.
  • A multi-group analysis (currently depressed, remitted, never depressed) provides a more comprehensive understanding of depression in MS.
  • This nuanced approach is essential for accurately characterizing and addressing depression in the MS population.